HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth prevention.

Abstract
We sought to identify maternal or clinical characteristics of women likely to develop preterm labor (PTL) at <34 weeks' gestation while receiving 17 alpha-hydroxyprogesterone caproate (17P) prophylaxis. Current singleton gestations with prior preterm delivery enrolled for outpatient 17P administration at <27 weeks' gestation were identified ( N = 1177). Maternal and clinical characteristics were compared between women hospitalized and diagnosed with PTL at <34 weeks' gestation (PTL group, N = 270) and those without PTL (No PTL group, N = 660). PTL at <34 weeks' gestation occurred in 270/1177 (22.9%) of patients receiving 17P prophylaxis (mean gestational age at diagnosis was 28.3 +/- 4.0 weeks). Recurrent preterm delivery occurred in 73.3% of women with PTL at <34 weeks. Maternal age, marital status, race, tobacco use, cerclage, gestational age at start of 17P, and Medicaid status were similar between the groups. Women developing PTL at <34 weeks were more likely to have >1 prior preterm delivery than those without PTL (35.2% versus 25.9%, P = 0.006, odds ratio [95% confidence interval] 1.5 [1.1, 2.1]). Women receiving 17P prophylaxis remain at increased risk for PTL and preterm birth. Patient education and surveillance for PTL symptoms may be warranted in women with a history of more than one prior preterm delivery.
AuthorsSaju Joy, Debbie J Rhea, Niki B Istwan, Cheryl N Desch, Gary Stanziano
JournalAmerican journal of perinatology (Am J Perinatol) Vol. 27 Issue 4 Pg. 343-8 (Apr 2010) ISSN: 1098-8785 [Electronic] United States
PMID20013580 (Publication Type: Comparative Study, Journal Article)
CopyrightThieme Medical Publishers.
Chemical References
  • 17-alpha-Hydroxyprogesterone
Topics
  • 17-alpha-Hydroxyprogesterone (administration & dosage)
  • Adult
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Fetal Monitoring (methods)
  • Follow-Up Studies
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Obstetric Labor, Premature (chemically induced, epidemiology, prevention & control)
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy, High-Risk
  • Premature Birth (prevention & control)
  • Probability
  • Recurrence
  • Retrospective Studies
  • Risk Assessment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: